Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Medarex, Inc.

Home Clinical Trial Sponsors and OrganizationsMedarex, Inc.

Medarex, Inc.

ACTIVE

707 State Rd Bldg A, Princeton, New Jersey, United Stateswww.medarex.comSubsidiary10,001+ employeesEstablished: 1987-01-01

Part of Bristol Myers Squibb Co.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

6

6 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1987

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

4

66.7%

Trial Status Distribution

Active, not recruiting

6

100.0%

Clinical Trials

Trials sponsored by this organization (6)

An Open-label, Fixed-dose, Multicenter, Phase II Study of MDX-060 in Patients with Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma - Not Available

Active, not recruiting

Apr 200645 participants

An Open-label, Fixed-dose, Multicenter, Phase II Study of MDX-060 in Patients with Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma - Not Available

Active, not recruiting

Feb 200645 participants

A Randomized, Double-Blind, Multicenter Study Comparing MDX-010 Monotherapy, MDX-010 in Combination with a Melanoma Peptide Vaccine, and Melanoma Peptide Vaccine Monotherapy in HLA-A*0201-Positive Patients with Previously Treated Unresectable Stage III or IV Melanoma - Not Available

Active, not recruiting

Feb 20061,051 participants

An Open-Label, Two-Stage, Fixed-Dose, Multicenter Phase II Study of MDX-060 in Patients with Relapsed or Refractory Hodgkin’s Disease - not available

Active, not recruiting

Feb 200584 participants

An Open-Label, Phase II Extension Study of MDX-060 in Patients with Relapsed or Refractory Hodgkin’s Disease Previously Treated in Protocol MDX060-03

Active, not recruiting

A Randomized, Double-Blind, Multicenter Study Comparing MDX-010 Monotherapy, MDX-010 in Combination with a Melanoma Peptide Vaccine, and Melanoma Peptide Vaccine Monotherapy in HLA-A*0201-Positive Patients with Previously Treated Unresectable Stage III or IV Melanoma - Not Available

Active, not recruiting

Feb 2005750 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials6
Approvals
News

Back to Organizations